반려동물 알레르기 치료 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global pet allergy treatment market size is expected to reach USD 4.93 Billion in 2034 from USD 2.73 Billion in 2025, growing at a CAGR of 6.79 during 2026-2034.This market is experiencing notable growth as pet ownership continues increasing while awareness regarding pet-related allergies expands globally. Individuals suffering from allergic reactions are seeking effective treatment options that reduce symptoms without limiting interactions with companion animals. Healthcare providers are offering a broader range of medications and therapeutic solutions to improve patient quality of life and support long-term allergy management.

Growing prevalence of allergic conditions, increasing healthcare awareness, and expanding access to allergy diagnostics are key drivers supporting market development. Pharmaceutical companies are introducing advanced antihistamines, immunotherapy treatments, nasal sprays, and biologic therapies that provide improved symptom control. Rising investments in allergy research and personalized healthcare solutions are also strengthening product innovation and commercial opportunities.

The future outlook remains favorable as advancements in immunotherapy, precision medicine, and biotechnology continue improving treatment effectiveness. Increasing pet adoption, expanding healthcare access, and growing consumer awareness regarding allergy management will support sustained market expansion. Ongoing clinical research and technological innovation are expected to introduce safer and more effective therapeutic options over the coming years.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Drug Class

• Antihistamines
• Corticosteroids
• Immunotherapy
• Monoclonal antibodies
• Microbiome-modulating agents
• Other Drug Classes

By Pet Type

• Dogs
• Cats
• Rabbits
• Other Companion Animals

By Route of Administration

• Oral
• Injectable
• Topical
• Sublingual

By Distribution Channel

• Veterinary Clinics & Hospitals
• Retail Pharmacies
• Online Pharmacies

COMPANIES PROFILED

• Zoetis Animal Health, Merck & Co. Inc. (MSD Animal, Health), Boehringer Ingelheim International GmbH, Elanco Animal Health, Ceva Sante Animale, Virbac, Dechra Pharmaceuticals, Vetoquinol, Neogen Corporation, Phibro Animal Health, Nextmune, Bioiberica S.A.U., IDEXX Laboratories, Allergy Therapeutics plc

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PET ALLERGY TREATMENT MARKET: BY DRUG CLASS 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Drug Class
• 4.2. Antihistamines Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Corticosteroids Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Immunotherapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Monoclonal antibodies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Microbiome-modulating agents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Other Drug Classes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PET ALLERGY TREATMENT MARKET: BY PET TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Pet Type
• 5.2. Dogs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Cats Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Rabbits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Other Companion Animals Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PET ALLERGY TREATMENT MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Route Of Administration
• 6.2. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Injectable Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Topical Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Sublingual Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PET ALLERGY TREATMENT MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Distribution Channel
• 7.2. Veterinary Clinics & Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PET ALLERGY TREATMENT MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Drug Class
  • 8.2.2 By Pet Type
  • 8.2.3 By Route Of Administration
  • 8.2.4 By Distribution Channel
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Drug Class
  • 8.3.2 By Pet Type
  • 8.3.3 By Route Of Administration
  • 8.3.4 By Distribution Channel
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Drug Class
  • 8.4.2 By Pet Type
  • 8.4.3 By Route Of Administration
  • 8.4.4 By Distribution Channel
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Drug Class
  • 8.5.2 By Pet Type
  • 8.5.3 By Route Of Administration
  • 8.5.4 By Distribution Channel
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Drug Class
  • 8.6.2 By Pet Type
  • 8.6.3 By Route Of Administration
  • 8.6.4 By Distribution Channel
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL PET ALLERGY TREATMENT INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Zoetis Animal Health
  • 10.2.2 Merck & Co. Inc. (MSD Animal Health)
  • 10.2.3 Boehringer Ingelheim International GmbH
  • 10.2.4 Elanco Animal Health
  • 10.2.5 Ceva Sant e Animale
  • 10.2.6 Virbac
  • 10.2.7 Dechra Pharmaceuticals
  • 10.2.8 Vetoquinol
  • 10.2.9 Neogen Corporation
  • 10.2.10 Phibro Animal Health
  • 10.2.11 Nextmune
  • 10.2.12 Bioiberica S.A.U
  • 10.2.13 IDEXX Laboratories
  • 10.2.14 Allergy Therapeutics Plc